2020
DOI: 10.2147/dddt.s238955
|View full text |Cite
|
Sign up to set email alerts
|

<p>Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles</p>

Abstract: Purpose: Hepatocellular carcinoma (HCC) is a leading cancer worldwide. In the present investigation, sorafenib (SFN) and curcumin (CCM) were co-delivered using pH-sensitive lactosylated nanoparticles (LAC-NPs) for targeted HCC treatment. Methods: pH-responsive lactosylated materials were synthesized. SFN and CCM codelivered, pH-responsive lactosylated nanoparticles (LAC-SFN/CCM-NPs) were selfassembled by using the nanoprecipitation technique. The nanoparticles were characterized in terms of particle size, char… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
19
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(21 citation statements)
references
References 64 publications
0
19
0
Order By: Relevance
“…In light of this, a number of research have been devoted on the solubility enhancements or encapsulation of curcumin targeted drug delivery platforms for biomedical applications ( Deljoo et al, 2019 ; Zare et al, 2019a ; Zare et al, 2019b ). For instance, a number of nanoscale carriers (e.g., micelles, liposomes, polymeric nanocarriers, lipid nanoparticles, and carbon nanotubes) have been developed to encapsulate hydrophobic active compounds such as curcumin ( Bian and Guo, 2020 ; Li et al, 2020b ; Hu et al, 2020 ; Varshosaz et al, 2020 ; Zhao et al, 2020 ). Such platforms enhanced the therapeutic efficacy of curcumin along with prolonged delivery.…”
Section: Curcumin: An Overview Of the Pharmacological Impacts And Limmentioning
confidence: 99%
“…In light of this, a number of research have been devoted on the solubility enhancements or encapsulation of curcumin targeted drug delivery platforms for biomedical applications ( Deljoo et al, 2019 ; Zare et al, 2019a ; Zare et al, 2019b ). For instance, a number of nanoscale carriers (e.g., micelles, liposomes, polymeric nanocarriers, lipid nanoparticles, and carbon nanotubes) have been developed to encapsulate hydrophobic active compounds such as curcumin ( Bian and Guo, 2020 ; Li et al, 2020b ; Hu et al, 2020 ; Varshosaz et al, 2020 ; Zhao et al, 2020 ). Such platforms enhanced the therapeutic efficacy of curcumin along with prolonged delivery.…”
Section: Curcumin: An Overview Of the Pharmacological Impacts And Limmentioning
confidence: 99%
“…This can contribute to a higher level of tumor cell cytotoxicity in an in vivo system. All NPs presented PDI values <0.2, considered to have a homogeneous narrow distribution [ 28 ]. Control NPs presented zeta potentials of −32.0 ± 0.5 mV and −31.0 ± 0.5 mV, while lactosylated NPs showed −28.0 ± 0.1 mV and −26.0 ± 0.2 for LC and HC, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, lactosylation of BSA it would not have a high influence on the Z potential of NPs. On the other hand, it is important to highlight that negative values indicate that clearance by the reticuloendothelial system (RES) could be reduced due to the low absorption of plasma proteins on the surface of the nanoparticles [ 28 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cell uptake extent of LPHNs was measured by encapsulating C-6 as an indicator (Bian & Guo, 2020 ). C-6 encapsulated TAB-CIS/5-FU LPHNs and CIS/5-FU LPHNs were added to BE-3 cells and incubated for 1 h. Cells were then washed with PBS (1 mL) and photographed by fluorescence microscopy.…”
Section: Methodsmentioning
confidence: 99%